Abstract:Local retroperitoneal recurrence (RPR) after radical nephrectomy (RN) is rare in patients with renal cell carci-noma (RCC); however, it is associated with poor prognosis and lacks standard treatment. This study compared the oncological outcomes of patients with RPR treated with RPR surgery or targeted therapy alone and assessed the prognostic factors of these patients, showing that treatment with RPR surgery resulted in signif-icantly longer CSS than targeted therapy alone. Introduction : Local retroperitoneal recurrence (RPR) after racial nephrectomy (RN) of renal cell carcinoma (RCC) remains a therapeutic challenge and has a poor prognosis. We aimed to compare the oncological outcomes of patients with RPR treated with RPR surgery or targeted therapy alone and assess the prognostic factors of these patients. Patients and Methods : This is a retrospective multi-center study of patients with RPR after prior RN treated with or without surgical treatment from 2008 to 2020. RPR of RCC is defined as an ipsilateral recurrence confined to the renal fossa, adrenal gland or retroperitoneal lymph nodes after prior nephrectomy, which was diagnosed by cross-sectional imaging. Clinical and pathological features, perioperative complications were reported using descrip-tive statistics. Cancer-specific survival (CSS) was evaluated by Kaplan-Meier method and studied using Cox propor-tional hazards model. Results : Median follow-up period was 35 months (IQR 20-61) for the RPR surgery group and 23 months (IQR 9-40.5) for the targeted therapy group. No patients had distant metastatic disease at the time of RPR diagnosis. Treatment with RPR surgery resulted in significantly longer CSS than targeted therapy alone ( P < .001). In multivariable analysis, high Fuhrman grade, size of RPR tumor, mixed type of RPR, multiple recurrence lesions and the absence of RPR surgery were associated with a significantly increased risk of death from RCC. Conclusion : Aggressive surgical resection of RPR after RN represents a potentially curative treatment for selected RCC patients without synchronous metastases, resulting in significantly longer CSS than targeted therapy alone.

Risk factors for recurrence and survival in patients with primary retroperitoneal tumors.

Surgical management and factors associated with postoperative recurrence for retroperitoneal liposarcoma:a multivariate analysis

Postoperative Recurrent Factors of Primary Retroperitoneal Tumor

Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience

Diagnosis and Treatment of Recurrent Primary Retroperitoneal Tumor

Resection Outcomes for Primary and Local Recurrent Retroperitoneal Liposarcoma Patients

Surgical treatment of primary retroperitoneal tumor:report of 42 cases

Management and prognosis of primary retroperitoneal tumors

Treatment algorithm and surgical outcome for primary and recurrent retroperitoneal sarcomas: A long-term single-center experience of 242 cases

Diagnosis and surgical treatment of primary retroperitoneal tumors: report of 63 cases

Prognostic factors of retroperitoneal neoplasms:a meta-analysis

Impact of Time to First Relapse on Long-Term Outcome in Adult Retroperitoneal Sarcoma Patients after Radical Resection

Management of Retroperitoneal Liposarcoma: A Case Report and Review of the Literature.

Prognostic Factors Predicting the Postoperative Survival Period Following Treatment for Primary Retroperitoneal Liposarcoma

Predictors and Outcomes of Recurrent Retroperitoneal Liposarcoma: New Insights into Its Recurrence Patterns

Prognostic Factors of Retroperitoneal Soft Tissue Sarcomas: Analysis of 132 Cases

A Retrospective, Single‑center Cohort Study on 65ï¿½patients with Primary Retroperitoneal Liposarcoma

Prognostic Factors in Patients with Recurrent or Metastatic Retroperitoneal Leiomyosarcoma.

[Primary Retroperitoneal Tumor--an Analysis of 303 Cases].

Clinicopathological risk factors of retroperitoneal liposarcoma recurrence-free survival after surgical resection

SURGICAL MANAGEMENT AND ONCOLOGIC OUTCOMES FOR LOCAL RETROPERITONEAL RECURRENCE OF RENAL CELL CARCINOMA AFTER RADICAL NEPHRECTOMY